Dali Zong

1.5k total citations
27 papers, 873 citations indexed

About

Dali Zong is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Dali Zong has authored 27 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Oncology and 4 papers in Genetics. Recurrent topics in Dali Zong's work include DNA Repair Mechanisms (16 papers), CRISPR and Genetic Engineering (8 papers) and PARP inhibition in cancer therapy (7 papers). Dali Zong is often cited by papers focused on DNA Repair Mechanisms (16 papers), CRISPR and Genetic Engineering (8 papers) and PARP inhibition in cancer therapy (7 papers). Dali Zong collaborates with scholars based in United States, Sweden and China. Dali Zong's co-authors include Rolf Lewensohn, Kristina Viktorsson, André Nussenzweig, Petra Hååg, Elsa Callén, Birgitta Mörk, Nancy Wong, Lovisa Lundholm, Wei Wu and Michael J. Kruhlak and has published in prestigious journals such as Science, Nucleic Acids Research and Genes & Development.

In The Last Decade

Dali Zong

25 papers receiving 868 citations

Peers

Dali Zong
Fenil Shah United States
Anderson T. Wang United Kingdom
Shaojie Jiang China
Tzeh Keong Foo United States
Jenifer R. Prosperi United States
Gastón Soria Argentina
Luzviminda Feeney United States
Anthony L. Sinn United States
Hong Yan United States
Marie Villedieu France
Fenil Shah United States
Dali Zong
Citations per year, relative to Dali Zong Dali Zong (= 1×) peers Fenil Shah

Countries citing papers authored by Dali Zong

Since Specialization
Citations

This map shows the geographic impact of Dali Zong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dali Zong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dali Zong more than expected).

Fields of papers citing papers by Dali Zong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dali Zong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dali Zong. The network helps show where Dali Zong may publish in the future.

Co-authorship network of co-authors of Dali Zong

This figure shows the co-authorship network connecting the top 25 collaborators of Dali Zong. A scholar is included among the top collaborators of Dali Zong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dali Zong. Dali Zong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Wu, Jianhua, Dali Zong, & Fei Li. (2025). Enhanced photodynamic therapy with riboflavin@ dual minerals doped hydroxyapatite nanoparticles: A promising in vitro approach for bladder cancer. Journal of Photochemistry and Photobiology B Biology. 270. 113207–113207. 2 indexed citations
4.
Zong, Dali, James A. Cornwell, Michael J. Kruhlak, et al.. (2023). Comprehensive mapping of cell fates in microsatellite unstable cancer cells supports dual targeting of WRN and ATR. Genes & Development. 37(19-20). 913–928. 9 indexed citations
5.
Wang, Dongpeng, Wei Wu, Elsa Callén, et al.. (2022). Active DNA demethylation promotes cell fate specification and the DNA damage response. Science. 378(6623). 983–989. 69 indexed citations
6.
Hååg, Petra, Magnus Olsson, Marita Lagergren Lindberg, et al.. (2022). Caspase-2 is a mediator of apoptotic signaling in response to gemtuzumab ozogamicin in acute myeloid leukemia. Cell Death Discovery. 8(1). 284–284. 2 indexed citations
7.
Setiaputra, Dheva, Cristina Escribano‐Diaz, Pooja Sadana, et al.. (2022). RIF1 acts in DNA repair through phosphopeptide recognition of 53BP1. Molecular Cell. 82(7). 1359–1371.e9. 21 indexed citations
8.
Shinoda, Kenta, Dali Zong, Elsa Callén, et al.. (2021). The dystonia gene THAP1 controls DNA double-strand break repair choice. Molecular Cell. 81(12). 2611–2624.e10. 17 indexed citations
9.
Tighe, Anthony, Darawalee Wangsa, Dali Zong, et al.. (2021). TP53 loss initiates chromosomal instability in fallopian tube epithelial cells. Disease Models & Mechanisms. 14(11). 15 indexed citations
10.
Wang, Yinan, Anthony Tubbs, Dali Zong, et al.. (2021). LIN37-DREAM prevents DNA end resection and homologous recombination at DNA double-strand breaks in quiescent cells. eLife. 10. 16 indexed citations
11.
Zong, Dali, et al.. (2019). ZNF488 is an independent prognostic indicator in nasopharyngeal carcinoma and promotes cell adhesion and proliferation via collagen IV/FAK/AKT/Cyclin D1 pathway. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Eke, Iris, Dali Zong, Molykutty J. Aryankalayil, et al.. (2019). 53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapy. Nucleic Acids Research. 48(3). 1314–1326. 17 indexed citations
13.
Callén, Elsa, Dali Zong, Wei Wu, et al.. (2019). 53BP1 Enforces Distinct Pre- and Post-resection Blocks on Homologous Recombination. Molecular Cell. 77(1). 26–38.e7. 83 indexed citations
14.
Zong, Dali, Salomé Adam, Yifan Wang, et al.. (2019). BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation. Molecular Cell. 73(6). 1267–1281.e7. 85 indexed citations
15.
Nacson, Joseph, John J. Krais, Andrea J. Bernhardy, et al.. (2018). BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance. Cell Reports. 24(13). 3513–3527.e7. 73 indexed citations
16.
Zong, Dali, et al.. (2015). Ectopic expression of RNF168 and 53BP1 increases mutagenic but not physiological non-homologous end joining. Nucleic Acids Research. 43(10). 4950–4961. 22 indexed citations
17.
Zong, Dali, Petra Hååg, Metka Novak, et al.. (2015). DKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines. BMC Cancer. 15(1). 628–628. 27 indexed citations
18.
Zong, Dali, et al.. (2014). Harnessing the lysosome-dependent antitumor activity of phenothiazines in human small cell lung cancer. Cell Death and Disease. 5(3). e1111–e1111. 36 indexed citations
19.
Lundholm, Lovisa, Petra Hååg, Dali Zong, et al.. (2013). Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest. Cell Death and Disease. 4(1). e478–e478. 90 indexed citations
20.
Zong, Dali, Petra Hååg, Ihor Yakymovych, Rolf Lewensohn, & Kristina Viktorsson. (2011). Chemosensitization by phenothiazines in human lung cancer cells: impaired resolution of γH2AX and increased oxidative stress elicit apoptosis associated with lysosomal expansion and intense vacuolation. Cell Death and Disease. 2(7). e181–e181. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fenil Shah Breakdown of academic impact, for papers by Anderson T. Wang Breakdown of academic impact, for papers by Shaojie Jiang Breakdown of academic impact, for papers by Tzeh Keong Foo Breakdown of academic impact, for papers by Jenifer R. Prosperi Breakdown of academic impact, for papers by Gastón Soria Breakdown of academic impact, for papers by Luzviminda Feeney Breakdown of academic impact, for papers by Anthony L. Sinn Breakdown of academic impact, for papers by Hong Yan Breakdown of academic impact, for papers by Marie Villedieu
Rankless by CCL
2026